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Case Report
Macular Infarction Associated with Reactive Arthritis
Ju-Young Kim, Jong-Hyuck Lee, Ie-Na Yoon 
Department of Ophthalmology, Wonju Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea 
A 53-year-old woman visited the Department of Rheumatology with a chief complaint of a 3-day history of fever and 
chills and also presented with pain occuring in both knees at the time of outpatient visit. Based on rheumatologic 
and hematological lab studies, ultrasonography, and a needle aspiration biopsy of the articular cavity, the patient 
was diagnosed with reactive arthritis. On hospitalization day 3, consultation with the Department of Ophthalmology 
was requested regarding decreased visual acuity lasting for 3 days. Upon ophthalmologic examination, the cor-
rected visual acuity was 0.1 in the right eye and 0.05 in the left eye. Upon slit lamp microscopy, there were no abnor-
mal findings in the anterior segment. Upon fundus examination, however, there were yellow-white lesions in the 
macular area of both eyes. Fluorescein angiographywas performed to assess the macular lesions, and the findings 
were suggestive of macular infarction in both eyes. Due to a lack of other underlying disease, a past surgical history, 
and a past history of drug administration, the patient was diagnosed with macular infarction in both eyes associated 
with reactive arthritis. To date, there have been no other such cases reported. In a patient with reactive arthritis, we 
experienced a case of macular infarction in both eyes, which occurred without association with a past history of spe-
cific drug use or underlying disease. Herein, we report our case, with a review of the literature. 
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Reactive arthritis is an acute nonpurulent arthritis that de-
velops from complications following the infection of other 
body areas and can occur due to various bacterial causes [1]. 
It is well known that reactive arthritis occurs due to the 
provocation of autoimmune responses because of sexual 
contact or bacterial infection via the gastrointestinal (GI) 
tract. To date, however, its overall pathophysiology has not 
been clarified. 
In 1986, Lee et al. [2] reported that the ophthalmic mani-
festations were present in 58% of 113 patients with reactive 
arthritis.
 Conjunctivitis was the most commonly reported 
ophthalmic manifestation of reactive arthritis. The occur-
rence of uveitis has also been reported in association with 
reactive arthritis [3]. In these cases, permanent loss of visual 
acuity can also occur. Other ophthalmic manifestations, 
such as keratitis, cataract, glaucoma, macular edema, papil-
litis, and scleritis have also been reported [3]. To date, how-
ever, no cases have been reported of reactive arthritis asso-
ciated with macular infarction.
In association with sickle cell disease, the use of dapsone, 
snake venom poisoning, the concomitant use of photo-
dynamic therapy and an intravitreal injection of tri-
amcinolone, an intravitreal injection of ganciclovir and an 
intravitreal injection of amikacin, the occurrence of macular 
infarction has been reported [4-9]. In a patient with reactive 
arthritis, who complained of the decreased visual acuity in 
both eyes, we experienced a case of macular infarction. 
Herein, we report our case, with a review of the literature. 
Case Report
A 53-year-old woman visited the Department of Rheu- 
matology with the chief complaint of a 3-day history of fe-
ver and chills and also presented with pain occuring in both 
knees at the time of the outpatient visit. The patient’s past 
history included no notable medical and surgical findings. 
Upon hematology performed following the hospitalization, 
the parameters were elevated to WBC 14,730/mm
2, ESR 55 
mm/hr, and CRP 13.29 mg/dL. Such negative results as 
ANA 1:80 (+), lupus anticoagulant 1.6, and HLA B27 were 
also reported. A blood culture test was also negative. Upon JY Kim, et al. Macular Infarction and Reactive Arthritis
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Fig. 1. Yellow-white lesions around fovea are shown in both eyes.
Fig. 2. Stratus OCT of both eyes revealed the hyper-reflectivity of the inner retina.
ultrasonography, a great amount of the effusion was present 
within the articular cavity. A fine-needle aspiration biopsy 
of the intra-articular cavity showed that the WBC count was 
increased to 900/mm
3. No other abnormal laboratory find-
ings than these findings were noted. Based on these findings 
and ruling out other rheumatic diseases, a diagnosis of re-
active arthritis was made.
On hospitalization day 3, consultation with the Department 
of Ophthalmology was requested regarding decreased visu-
al acuity lasting for 3 days. Upon ophthalmic examination, 
her corrected visual acuity was 0.1 in her right eye and 0.05 
in her left eye. Intraocular pressure was 12 mmHg in both 
eyes. Upon slit lamp microscopy, there were no abnormal 
findings in the anterior segment. Upon fundus exam, how-
ever, there were yellow-white lesions in the macular area of 
both eyes (Fig. 1). Optical coherence tomography (Stratus 
OCT; Carl Zeiss Meditec, Oberkochen, Germany) of both 
eyes revealed the hyperreflectivity of the inner retina (Fig. 
2). Upon fluorescein angiography, the avascular area of the 
fovea was markedly enlarged (Fig. 3). Based on these find-
ings, the patient was diagnosed with macular infarction in 
both eyes. Due to a lack of other causative factors, such as 
other underlying diseases, a past surgical history, a past his-
tory of ophthalmic trauma, and a past history of drug admin-
istration, the patient was diagnosed with macular infarction 
in both eyes associated with reactive arthritis. 
After 4 weeks, corrected visual acuity was 0.1 (-1) in her 
right eye and finger count discrimination occurred in her 
left eye. 
Discussion
Reactive arthritis is a joint disease associated with 
HLA-B27, which also occurs in association with GI tract in-
fections or urogenital tract infections. A cell-mediated im-
munity is induced by the infectious pathogenic antigens. It 
has been postulated that the antigen-specific CD4 T-cells 
and CD8 T-cells are activated within the articular cavity, 
and this causes the inflammatory response within the tissue. 
It causes the inflammations in such areas as the joints, in-Korean J Ophthalmol Vol.24, No.5, 2010
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Fig. 3. Fluorescence angiography showing a marked increase in size of the foveal avascular zone. 
sertions of tendons, skin, mucosa, GI tract, and eyes.
Such ophthalmic manifestations as conjunctivitis or uvei-
tis have been commonly reported to occur in association 
with the concurrent presence of ophthalmic problems [3]. 
To date, however, there are no cases of macular infarction 
which has been developed in association with reactive 
arthritis. 
Macular infarction can develop due to these hemato-
logical problems. In sickle cell anemia, sickle-shaped RBCs 
increase the blood viscosity and thereby can trigger such 
symptoms as vascular obstruction, ischemia, hypoxia, and 
tissue necrosis [4]. Snake venom can also cause tissue ne-
crosis because of the derangement of blood coagulation cas-
cades [6]. By contrast, macular infarction due to dapsone or 
amikacin occurs as a result of the drug toxicity itself [5,9]. 
In our case, however, there were no causative factors that 
have previously been reported to be related to macular 
infarction. However, one of the causative factors, if any, for 
macular infarction in this case would be the increased level 
of lupus anticoagulant, one of the anti-phospholipid anti-
bodies, among laboratory findings. Based on these labo-
ratory findings, it can be inferred that this case is associated 
with anti-phospholipid syndrome.
Antiphospholipid syndrome is a disorder characterized 
by a wide variety of clinical manifestations. Virtually any 
organ system or tissue may be affected by the consequences 
of large- or small-vessel thrombosis. A broad spectrum of 
disease exists among individuals with antiphospholipid an-JY Kim, et al. Macular Infarction and Reactive Arthritis
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tibodies [10].
A review of the literature found a correlation between re-
active arthritis and antiphospholipid syndrome [11]. It has 
also been reported that such ophthalmic manifestations as 
ocular ischemic syndrome, anterior ischemic optic neuro-
pathy, central retinal vein occlusion, branched retinal vein 
occlusion, and retinal vasculitis have occurred in associa-
tion with antiphospholipid syndrome [12]. Also, in our 
case, the serum level of lupus anticogulant was elevated 
upon laboratory tests. It is probable that macular infarction 
occurred due to macular thrombosis, because the increased 
level of lupus anticoagulant exacerbated the mechanisms of 
blood coagulation. However, other than the elevated level 
of lupus anticoagulant, such laboratory findings associated 
with blood coagulation as prothrombin time and partial 
thromboplastin time were all normal. Besides, the patient 
had no past history of thrombosis. Therefore, our patient’s 
case could not meet all of the criteria for a diagnosis of anti-
phospholipid syndrome. Still, although rare, a greater num-
ber of cases will be needed to establish the causal relation-
ship between the two diseases. 
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